Best medication for restless legs syndrome, honestly
There is no single "best" drug for restless legs syndrome — and the honest starting point isn't a drug at all. Below, the options are grouped by their real role in treatment, with what each is, whether it's FDA-approved for RLS or used off-label, the trade-off that decides it, and our independent recall-safety rating. The fact most patients are never told — augmentation — is stated on every drug it applies to, and on every drug it does not.
The honest first move isn't a prescription
Start by checking iron. Restless legs is frequently driven by low body-iron stores, and correcting them can settle the symptoms without any RLS drug — so a ferritin blood test comes before a prescription. When a drug is needed, guidelines have shifted: the alpha-2-delta ligands (gabapentin enacarbil, gabapentin, pregabalin) are now often preferred first, because the older dopamine agonists (ropinirole, pramipexole, rotigotine) cause augmentation — the RLS slowly gets worse and spreads over months on the drug — and also carry warnings for impulse-control disorders and for falling asleep suddenly during the day. That trade-off, more than any head-to-head potency, is what decides the modern choice.
Check your iron first (ferritin) + triggers
First step — not a medication
The most important move in RLS is not a prescription. Low body iron is one of the commonest drivers, and the fix can be as simple as replacing it — so a ferritin and iron-saturation blood test comes first. Iron stores matter more here than for ordinary anaemia: many clinicians treat when ferritin is under about 75 ng/mL (a higher bar than the anaemia cut-off), usually with oral iron, and with an intravenous infusion when tablets aren't absorbed or tolerated. Alongside that, look at triggers you can change: caffeine, alcohol and nicotine worsen RLS, and several common medicines provoke it — sedating antihistamines such as diphenhydramine, dopamine-blocking anti-nausea drugs (metoclopramide, prochlorperazine) and most antidepressants (mirtazapine especially, and the SSRIs and SNRIs). Correcting iron or removing a trigger settles some cases without any RLS drug at all.
Gabapentin enacarbil (Horizant)
Alpha-2-delta ligand (gabapentinoid)
The only alpha-2-delta ligand FDA-approved specifically for moderate-to-severe primary RLS, and increasingly a first choice — it does NOT cause augmentation, the slow worsening that undermines the dopamine agonists, and it helps sleep and any coexisting pain. Taken as 600 mg once daily at about 5 PM with food. The main effects are drowsiness and dizziness, so the label warns against driving until you know how it affects you; it can also cause weight gain and ankle swelling. Like the whole class it carries a warning about serious breathing problems (respiratory depression) when combined with opioids or other CNS depressants, and the antiepileptic-class warning about new or worsening depression and suicidal thoughts. It is cleared by the kidneys, so the dose is reduced in kidney impairment and it is not recommended for people on dialysis. Do not stop it abruptly. It is not a federally controlled substance.
Pramipexole (Mirapex)
Dopamine agonist
A dopamine agonist FDA-approved for moderate-to-severe primary RLS (immediate-release Mirapex; the extended-release form is for Parkinson's, not RLS). Effective early, with the same class trade-off that has demoted this whole group: AUGMENTATION — the RLS worsening, starting earlier and spreading over months of use, plus rebound as each dose wears off. It carries the same labeled warnings as ropinirole for impulse-control disorders (compulsive gambling, shopping, eating, hypersexuality), for falling asleep suddenly during activities including driving, and for dizziness or fainting on standing. Unlike ropinirole, pramipexole is cleared by the kidneys, so the dose is reduced in kidney impairment. Not a controlled substance.
Ropinirole (Requip)
Dopamine agonist
A dopamine agonist FDA-approved for moderate-to-severe primary RLS (the immediate-release Requip; the extended-release Requip XL is a Parkinson's drug, not for RLS). It works quickly and well in the first months, which is its appeal — but its labeled risks are why guidelines increasingly hold it back. The most important is AUGMENTATION: over months the RLS gets worse on the drug — starting earlier in the day, growing more intense and spreading to the arms — and raising the dose to chase it makes it worse. It also carries a warning for impulse-control disorders (new compulsive gambling, shopping, eating or hypersexuality that patients often don't connect to the drug — ask family), for suddenly falling asleep during the day including while driving, and for dizziness or fainting on standing. Ropinirole is cleared by the liver rather than the kidneys. Not a controlled substance.
Rotigotine patch (Neupro)
Dopamine agonist (skin patch)
The same drug class as ropinirole and pramipexole, but delivered continuously through a once-daily skin patch, and FDA-approved for moderate-to-severe primary RLS. The steady 24-hour delivery is its advantage: AUGMENTATION still happens, but at lower rates than with the short-acting oral agents, which is why the patch is sometimes preferred when a dopamine agonist is used. It carries the same class warnings as the oral agents — impulse-control disorders (gambling, shopping, eating, hypersexuality), suddenly falling asleep during the day including while driving, and dizziness or fainting on standing. Its own quirks: application-site skin reactions are common (rotate the site), and the patch contains a sulfite (sodium metabisulfite) that can trigger a reaction in sulfite-sensitive people. Not a controlled substance.
Gabapentin (Gralise / Neurontin)
Alpha-2-delta ligand (gabapentinoid)
The same class as gabapentin enacarbil and effective for RLS, but used OFF-LABEL — plain gabapentin (Gralise, Neurontin, generic) is FDA-approved for post-shingles nerve pain and seizures, not RLS, so its RLS use rests on trials and guidelines rather than a label indication. Usually taken in the evening; an inexpensive choice, particularly when pain accompanies the RLS. Like enacarbil it does NOT cause augmentation. Side effects are dizziness, drowsiness, weight gain and ankle swelling. It carries the same class warning about serious breathing problems with opioids or other CNS depressants, and the antiepileptic-class warning about depression and suicidal thoughts. It is cleared by the kidneys, so the dose is reduced in kidney impairment. Not a federally controlled substance. Do not stop it abruptly.
Pregabalin (Lyrica)
Alpha-2-delta ligand (gabapentinoid)
Also an alpha-2-delta ligand, effective for RLS in trials but used OFF-LABEL — pregabalin is FDA-approved for nerve pain, fibromyalgia and seizures, not RLS. Taken in the evening; like the others in this class it does NOT cause augmentation, which is the reason the class is now often preferred over dopamine agonists. It differs from gabapentin in two ways worth knowing: it is a Schedule V controlled substance (a low but real dependence potential the other two do not carry), and its label warns about angioedema — swelling of the face, mouth or throat that can threaten the airway. Otherwise the profile matches the class: dizziness, drowsiness, weight gain and ankle swelling; the serious-breathing-problem warning with opioids or other CNS depressants; the antiepileptic-class warning about depression and suicidal thoughts; and a dose reduced in kidney impairment. Do not stop it abruptly.
How to choose
The honest way to narrow it down — matched to your situation, not a ranking. These are common scenarios, not a complete rulebook; the final choice is a prescriber’s.
- You haven't had your iron checked
- A ferritin and iron-saturation blood test first — replacing low iron can fix RLS with no RLS drug at all. This comes before choosing a medicine, not after.
- You want a drug but want to avoid augmentation
- An alpha-2-delta ligand — gabapentin enacarbil (the FDA-approved one for RLS), or gabapentin or pregabalin off-label. None of the three cause augmentation.
- RLS comes with pain, anxiety or trouble sleeping
- An alpha-2-delta ligand, which tends to help all three; gabapentin enacarbil is taken once in the early evening with food.
- You need relief soon and accept the long-term trade-off
- A dopamine agonist works fast — but discuss augmentation and impulse-control risk first, and keep the dose as low as it can go.
- A dopamine agonist is chosen and steadier delivery is wanted
- The rotigotine patch, whose continuous 24-hour delivery carries lower augmentation rates than the short-acting oral agents.
- You have kidney impairment
- This narrows the field — gabapentin enacarbil, gabapentin, pregabalin and pramipexole all need a reduced dose; ropinirole is cleared by the liver instead.
Restless legs syndrome medications at a glance
| Medication | Class | FDA-approved for RLS? | Causes augmentation? | Key watch-outs |
|---|---|---|---|---|
| Gabapentin enacarbil (Horizant) | Alpha-2-delta ligand | Yes | No | Drowsiness, dizziness; breathing risk with opioids; renal dose cut |
| Gabapentin (Gralise/Neurontin) | Alpha-2-delta ligand | No — off-label | No | Drowsiness, weight gain; breathing risk with opioids; renal dose cut |
| Pregabalin (Lyrica) | Alpha-2-delta ligand | No — off-label | No | Schedule V; angioedema; breathing risk with opioids; renal dose cut |
| Ropinirole (Requip) | Dopamine agonist | Yes | Yes | Impulse-control disorders; sudden daytime sleep; augmentation |
| Pramipexole (Mirapex) | Dopamine agonist | Yes | Yes | Impulse-control disorders; sudden sleep; renal dose cut; augmentation |
| Rotigotine patch (Neupro) | Dopamine agonist | Yes | Yes (lower rate) | Impulse-control disorders; skin reactions; contains a sulfite |
What to expect
These are common situations, not a complete rulebook — the right choice is individual. Expect iron to be checked first; if stores are low, replacing them may be the whole treatment, and can take weeks to months to show. When a drug is used, it is started low and raised slowly, and reviewed for whether it helps sleep and evening symptoms. Alpha-2-delta ligands are taken in the evening and can cause daytime drowsiness at first that often eases. With any dopamine agonist, the thing watched for over the following months is augmentation — RLS starting earlier in the day, growing stronger or spreading — because the instinct to raise the dose is exactly what makes it worse; the fix is a prescriber review, not more drug. None of these medicines are stopped abruptly.
When to get medical help
- Your RLS is getting WORSE on a dopamine agonist — starting earlier in the day, feeling more intense, or spreading to your arms. This is augmentation; don't raise the dose yourself — it needs a prescriber review and often a change of drug.
- New compulsive gambling, shopping, eating or sexual urges on ropinirole, pramipexole or rotigotine — impulse-control disorders that patients rarely link to the drug. Ask family, and tell your prescriber.
- Falling asleep suddenly during the day — mid-conversation or while driving — on any dopamine agonist. Stop driving and contact your prescriber.
- Slow or shallow breathing, extreme sleepiness, or bluish lips on gabapentin enacarbil, gabapentin or pregabalin — the serious breathing risk that rises sharply when these are combined with opioids, sedatives or alcohol. Call emergency services.
- Swelling of the face, lips, tongue or throat, or trouble breathing — a possible allergic or angioedema reaction, warned about especially with pregabalin and gabapentin.
- New or worsening depression, agitation or thoughts of self-harm on any alpha-2-delta ligand — an antiepileptic-class warning; get help promptly, in the US call or text 988.
- Dizziness or fainting when you stand up on a dopamine agonist — a known blood-pressure effect; sit or lie down and tell your prescriber.
- Symptoms in only one leg, or with swelling, pain, numbness or weakness — this may not be RLS at all (a clot or a nerve problem) and needs a different work-up.
Frequently asked questions
What is the best medication for restless legs syndrome?
There isn't a single best — and the honest first step isn't a drug. Check iron: low body-iron stores are a common, reversible cause, and correcting them can settle RLS on their own. When a medicine is needed, guidelines now often start with an alpha-2-delta ligand — gabapentin enacarbil is the one FDA-approved for RLS; gabapentin and pregabalin are used off-label — rather than a dopamine agonist, because the agonists cause augmentation over time. The right pick depends on kidney function, coexisting pain or sleep problems, and cost.
Why are doctors moving away from ropinirole and pramipexole?
Because of augmentation. These dopamine agonists work well at first, but over months they can make RLS worse — symptoms start earlier in the day, grow more intense and spread to the arms — and raising the dose makes it worse still. They also carry warnings for impulse-control disorders (compulsive gambling, shopping, eating or sexual behaviour) and for falling asleep suddenly during the day. For those reasons many current guidelines reserve or limit them rather than starting with them.
What is augmentation in RLS?
Augmentation is when the drug that was helping starts to make the restless legs worse. The symptoms begin earlier in the day, feel more intense, need a shorter time to appear at rest, and can spread to the arms or trunk. It develops over months to years and is specific to the dopamine agonists (ropinirole, pramipexole, rotigotine) — the alpha-2-delta ligands do not cause it. The instinct to increase the dose is exactly what fuels augmentation, so it is handled by a prescriber review, not more drug.
Can low iron cause restless legs?
Yes — it is one of the commonest reversible drivers, which is why a ferritin blood test comes before a prescription. Iron matters more here than for ordinary anaemia: many clinicians treat when ferritin is under about 75 ng/mL (a higher bar than the usual anaemia threshold), with oral iron, or an intravenous infusion when tablets aren't absorbed or tolerated. In some people, replacing iron settles the RLS without any RLS-specific drug.
Is gabapentin or pregabalin approved for restless legs?
Gabapentin enacarbil (Horizant) IS FDA-approved specifically for moderate-to-severe primary RLS. Plain gabapentin (Gralise, Neurontin) and pregabalin (Lyrica) are used OFF-LABEL for RLS — they are approved for nerve pain, seizures or fibromyalgia — but they are supported by trials and guidelines. One practical difference: pregabalin is a Schedule V controlled substance, while gabapentin and gabapentin enacarbil are not federally scheduled.
Do restless legs medications cause weight gain?
The alpha-2-delta ligands (gabapentin, pregabalin, gabapentin enacarbil) can cause weight gain and ankle swelling, along with drowsiness and dizziness. The dopamine agonists are less associated with weight gain, but they bring their own trade-offs — augmentation, impulse-control disorders and sudden daytime sleepiness — so the choice is between different risks, not a clearly lighter one.
What drinks or medicines make restless legs worse?
Caffeine, alcohol and nicotine all worsen RLS. Several medicines provoke it too: sedating antihistamines such as diphenhydramine, dopamine-blocking anti-nausea drugs (metoclopramide, prochlorperazine), and most antidepressants — mirtazapine especially, and the SSRIs and SNRIs. Reviewing these, and adjusting where possible, is worth doing before adding an RLS drug on top.
Guides for these medications
Sources
Treatment-role framing follows standard US clinical guidelines; each drug links to its FDA label and our rating. This is general reference information, not medical advice, and not a recommendation to take any drug — the choice is a decision to make with a clinician. If you are in crisis, call or text 988 (the US Suicide & Crisis Lifeline).